Company: LICN
Filing Date: 2025-02-12
Form Type: 6-K
Source: 0001213900-25-012915
Chunk: 1

Company: Lichen International Ltd
Filing Date: 2025-02-12
Form: 6-K
Chunk 1
---
US$0.00004 each and (b) 250,000,000 series B ordinary shares of par value US$0.00004 each, to US$1,000,000.00 divided into (a) 20,000,000,000
series A ordinary shares of par value US$0.00004 each and (b) 5,000,000,000 series B ordinary shares of par value US$0.00004 each, by
the creation of additional (a) 19,000,000,000 series A ordinary shares of par value US$0.00004 each and (b) 4,750,000,000 series B ordinary
shares of par value US$0.00004 each to rank pari passu in all respects with the existing shares in the capital of the Company be and is
hereby approved (the “Share Capital Increase”); and (b) any one director of the Company be and is hereby authorised to do
all such acts and things and execute all such documents, including under seal where applicable, as he or she may consider necessary or
desirable to give effect to the Share Capital Increase and the transactions contemplated thereunder and to attend to any necessary registration
and/or filing in the Cayman Islands for and on behalf of the Company.”

2. As an ordinary resolution,

“That (a) the consolidation
of the Company’s issued and unissued series A and series B ordinary shares at a ratio of not less than one (1)-for-twenty (20) and
not more than one (1)-for-two hundred (200) (the “Range”), with the exact ratio to be set at a whole number within the Range
and the exact effective date to be determined by the board of directors of the Company (the “Board”) in its sole discretion
within one year after the date of passing of this resolution (the “Share Consolidation”), provided that no fractional share
shall arise from the Share Consolidation, be and is hereby approved; (b) the rounding up of any fractional shares resulting from the Share
Consolidation to the nearest whole ordinary share be and is hereby approved and (c) the Board be and is hereby authorised to do all such
acts and things and execute all such documents, including under seal where applicable, as the Board considers necessary or desirable to
give effect to the Share Consolidation and the transactions contemplated thereunder, including determining the exact ratio within the
Range and the exact